Millipore Sigma Vibrant Logo

325877 FGFR1, GST-Fusion, Human, Recombinant, S. frugiperda

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: Fibroblast Growth Factor Receptor 1, Flt-2

325877
  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information
      Description
      Overview

      This product has been discontinued.






      Recombinant, human FGFR1 fused at the N-terminus to a GST-His6-thrombin cleavage site sequence and expressed in S. frugiperda insect cells. FGFR1 is a receptor tyrosine kinase that is involved in important processes such as cell division, regulation of cell growth and maturation, formation of blood vessels, wound healing, and embryonic development.
      Catalogue Number325877
      Brand Family Calbiochem®
      SynonymsFibroblast Growth Factor Receptor 1, Flt-2
      References
      ReferencesDvorak, P., et. al. 2005. Stem Cells 23, 1200.
      Antoine, M., et al. 2005. Growth Factors 23, 87.
      Johnson, D.E. and Williams, L.T. 1993. Adv. Cancer Res. 60, 1.
      Product Information
      Unit of DefinitionOne unit is defined as the amount of enzyme that will transfer 1 nmol phosphate to Poly(Glu,Tyr)<sub>4:1</sub> per min at 30°C, using variable concentrations from 0.1 µM to 8.42 µM ATP.
      FormLiquid
      FormulationIn 100 mM NaCl, 50 mM Tris-HCl, 5 mM DTT, 4 mM reduced glutathione, 20% glycerol, pH 8.0.
      Applications
      Biological Information
      Specific Activity≥15 U/mg protein
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      325877 0

      Documentation

      FGFR1, GST-Fusion, Human, Recombinant, S. frugiperda Certificates of Analysis

      TitleLot Number
      325877

      References

      Reference overview
      Dvorak, P., et. al. 2005. Stem Cells 23, 1200.
      Antoine, M., et al. 2005. Growth Factors 23, 87.
      Johnson, D.E. and Williams, L.T. 1993. Adv. Cancer Res. 60, 1.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision23-August-2007 JSW
      SynonymsFibroblast Growth Factor Receptor 1, Flt-2
      DescriptionRecombinant, human FGFR1 fused at the N-terminus to a GST-His6-thrombin cleavage site sequence and expressed in S. frugiperda insect cells. FGFR1 is a receptor tyrosine kinase that is involved in important processes such as cell division, regulation of cell growth and maturation, formation of blood vessels, wound healing, and embryonic development.
      FormLiquid
      FormulationIn 100 mM NaCl, 50 mM Tris-HCl, 5 mM DTT, 4 mM reduced glutathione, 20% glycerol, pH 8.0.
      Concentration Label Please refer to vial label for lot-specific concentration
      Recommended reaction conditions
      96-Well Membrane Binding Kinase Activity Assay Protocol:
      Materials Required • Standard Kinase Assay Buffer: 125 mM HEPES-NaOH, 7.5 mM MgCl2, 7.5 mM MnCl2, 7.5 µM sodium -orthovanadate, 2.5 mM DTT, pH 7.5 • 10X Kinase Dilution Buffer: 500 mM HEPES-NaOH, 2.5 mg/ml PEG20.000, 10 mM DTT, pH 7.5 • Substrate: Poly(Glu,Tyr)4:1, 2 µg/50 µl final concentration • FGFR1, GST-Fusion, Human, Recombinant, S. frugiperda, diluted in 1X Kinase Dilution Buffer to desired concentration (we use 50 ng in a 50 µl reaction) • 33P-γ-ATP • ATP Mix: 1 µM ATP in H2O with 1 x 106 cpm/5 µl • 96-well V-bottom MTP (polypropylene) plates (Nunc Cat. No. 442587) • 96-well Multiscreen Vacuum Manifold (Millipore Cat. No. MAVM096OR) • 96-well Multiscreen Filterplates, phosphocellulose membrane (Millipore Cat. No. MSPH N6B50) and glass fiber (Millipore Cat. No. MSFC N6B50) • 2% H3PO4 • 0.9% NaCl
      Activity Assay Protocol 1. In a polypropylene V-bottom plate add 20 µl Kinase Assay Buffer 2. If desired, add 5 µl test substance (e.g., inhibitor, activator, etc.; in 10% DMSO) 3. Add 10 µl Substrate (diluted in H2O). 4. Add 10 µl diluted FGFR1. 5. Add 5 µl ATP Mix. 6. Mix on a shaker and incubate at 30°C for 80 min. 7. Stop the reaction with 50 µl H3PO4. 8. Prewet the filter plate with 200 µl H2O. 9. Filter the reaction mix by applying vacuum. 10. Wash 3 times with 200 µl 0.9% NaCl. 11. Add 200 µl scintillation fluid to each well and count on a scintillation counter.
      Specific activity≥15 U/mg protein
      Unit definitionOne unit is defined as the amount of enzyme that will transfer 1 nmol phosphate to Poly(Glu,Tyr)4:1 per min at 30°C, using variable concentrations from 0.1 µM to 8.42 µM ATP.
      Storage Avoid freeze/thaw
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Toxicity Standard Handling
      ReferencesDvorak, P., et. al. 2005. Stem Cells 23, 1200.
      Antoine, M., et al. 2005. Growth Factors 23, 87.
      Johnson, D.E. and Williams, L.T. 1993. Adv. Cancer Res. 60, 1.